Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
44.66
+5.79 (14.90%)
Nov 6, 2026, 1:14 PM EST - Market open
Edgewise Therapeutics Market Cap
Edgewise Therapeutics has a market cap or net worth of $4.89 billion as of November 6, 2026. It is the 4,054th most valuable company in the world and the 1,270th biggest in the United States. Its market cap has increased by 167.21% in one year.
Market Cap
4.89B
Enterprise Value
3.15B
1-Year Change
167.21%
Global Rank
Country Rank
#1,270 United States
Category
ChartMarket Cap Chart
Since the IPO on March 26, 2021, Edgewise Therapeutics's market cap has increased from $761.07M to $4.89B, an increase of 542.45%. That is a compound annual growth rate of 39.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 4.89B | 86.12% |
| Dec 31, 2025 | 2.63B | 3.91% |
| Dec 31, 2024 | 2.53B | 264.15% |
| Dec 29, 2023 | 694.27M | 22.85% |
| Dec 30, 2022 | 565.13M | -24.97% |
| Dec 31, 2021 | 753.24M | -1.03% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Legend Biotech | 4.41B |
| Definium Therapeutics | 4.39B |
| Arcutis Biotherapeutics | 4.28B |
| AbCellera Biologics | 3.98B |
| Relay Therapeutics | 3.95B |
| Iovance Biotherapeutics | 3.94B |
| Tango Therapeutics | 3.91B |
| Xenon Pharmaceuticals | 3.80B |